Sequence variants of elaC homolog 2 (Escherichia coli) (ELAC2) gene and susceptibility to prostate cancer in the Health Professionals Follow-Up Study

Carcinogenesis

Volumn 29, Issue 5, 2008, Pages 999-1004

  Chen, Yen Ching ^a,b   Giovannucci, Edward ^a,c   Kraft, Peter ^c   Hunter, David J ^a,c  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^c HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE; LEUCINE; ONCOPROTEIN; PROSTATE SPECIFIC ANTIGEN; PROTEIN ELAC2; SERINE; THREONINE;

ADULT; AGED; ARTICLE; BLOOD ANALYSIS; CANCER RISK; CANCER SUSCEPTIBILITY; CASE CONTROL STUDY; CHROMOSOME 17P; CONFIDENCE INTERVAL; CONTROLLED STUDY; FOLLOW UP; GENE SEQUENCE; GENETIC ASSOCIATION; HAPLOTYPE; HEALTH PRACTITIONER; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROMOTER REGION; PROSTATE CANCER; RISK ASSESSMENT; SEQUENCE HOMOLOGY; SINGLE NUCLEOTIDE POLYMORPHISM; STATISTICAL SIGNIFICANCE;

ADULT; AGED; CASE-CONTROL STUDIES; COHORT STUDIES; DNA, NEOPLASM; FOLLOW-UP STUDIES; GENETIC PREDISPOSITION TO DISEASE; HUMANS; LINKAGE DISEQUILIBRIUM; MALE; MIDDLE AGED; NEOPLASM PROTEINS; POLYMORPHISM, SINGLE NUCLEOTIDE; PROSTATIC NEOPLASMS; VARIATION (GENETICS);

EID: 47249156126     PISSN: 01433334     EISSN: 14602180     Source Type: Journal    
DOI: 10.1093/carcin/bgn081     Document Type: Article

References (37)

1. Tavtigian,S.V. et al. (2001) A candidate prostate cancer susceptibility gene at chromosome 17p. Nat. Genet., 27, 172-180.
2. Dumont,M. et al. (2004) Structure of primate and rodent orthologs of the prostate cancer susceptibility gene ELAC2. Biochim. Biophys. Acta, 1679, 230-247.
3. Smith,M.M. et al. (2004) The Caenorhabditis elegans homolog of the putative prostate cancer susceptibility gene ELAC2, hoe-1, plays a role in germline proliferation. Dev. Biol., 266, 151-160.
4. Dronkert,M.L. et al. (2000) Disruption of mouse SNM1 causes increased sensitivity to the DNA interstrand cross-linking agent mitomycin C. Mol. Cell. Biol., 20, 4553-4561.
5. Takahashi,H. et al. (2003) Ser217Leu polymorphism of the HPC2/ ELAC2 gene associated with prostatic cancer risk in Japanese men. Int. J. Cancer, 107, 224-228.
6. Fujiwara,H. et al. (2002) Association of common missense changes in ELAC2 (HPC2) with prostate cancer in a Japanese case-control series. J. Hum Genet., 47, 641-648.
7. Yokomizo,A. et al. (2004) HPC2/ELAC2 polymorphism associated with Japanese sporadic prostate cancer. Prostate, 61, 248-252.
8. Shea,P.R. et al. (2002) ELAC2 and prostate cancer risk in Afro-Caribbeans of Tobago. Hum Genet., 111, 398-400.
9. Rebbeck,T.R. et al. (2000) Association of HPC2/ELAC2 genotypes and prostate cancer. Am. J. Hum. Genet., 67, 1014-1019.
10. Rokman,A. et al. (2001) ELAC2/BPC2 involvement in hereditary and sporadic prostate cancer. Cancer Res., 61, 6038-6041.
11. Wang,L. et al. (2001) Role of HPC2/ELAC2 in hereditary prostate cancer. Cancer Res., 61, 6494-6499.
12. Xu,J. et al. (2001) Evaluation of linkage and association of BPC2/ ELAC2 in patients with familial or sporadic prostate cancer. Am. J. Hum. Genet., 68, 901-911.
13. Nupponen,N.N. et al. (2004) Mutational analysis of susceptibility genes RNASEL/HPC1, ELAC2/HPC2, and MSR1 in sporadic prostate cancer. Genes Chromosomes Cancer, 39, 119-125.
14. Rennert,H. et al. (2005) Association of susceptibility alleles in ELAC2/HPC2, RNASEL/HPC1, and MSR1 with prostate cancer severity in European American and African American men. Cancer Epidemiol. Biomarkers Prev., 14, 949-957.
15. Suarez,B.K. et al. (2001) Polymorphisms in the prostate cancer susceptibility gene HPC2/ELAC2 in multiplex families and healthy controls. Cancer Res., 61, 4982-4984.
16. Meitz,J.C. et al. (2002) HPC2/ELAC2 polymorphisms and prostate cancer risk: Analysis by age of onset of disease. Br. J. Cancer, 87, 905-908.
17. Stanford,J.L. et al. (2003) Association of HPC2/ELAC2 polymorphisms with risk of prostate cancer in a population-based study. Cancer Epidemiol. Biomarkers Prev., 12, 876-881.
18. Severi,G. et al. (2003) ELAC2/HPC2 polymorphisms, prostate-specific antigen levels, and prostate cancer. J. Natl Cancer Inst., 95, 818-824.
19. Adler,D. et al. (2003) HPC2/ELAC2 gene variants associated with incident prostate cancer. J. Hum. Genet., 48, 634-638.
20. Vesprini,D. et al. (2001) BPC2 variants and screen-detected prostate cancer. Am. J. Hum. Genet., 68, 912-917.
21. Stampfer,M.J. et al. (1984) Test of the National Death Index. Am. J. Epidemiol., 119, 837-839.
22. Camp,N.J. et al. (2005) Characterization of linkage disequilibrium structure, mutation history, and tagging SNPs, and their use in association analyses: ELAC2 and familial early-onset prostate cancer. Genet. Epidemiol., 28, 232-243.
23. Platz,E.A. et al. (2005) Sex steroid hormones and the androgen receptor gene CAG repeat and subsequent risk of prostate cancer in the prostate-specific antigen era. Cancer Epidemiol. Biomarkers Prev., 14, 1262-1269.
24. Clayton,D. (2002) SNPHAP: A Program for Estimating Frequencies of Large Haplotypes of SNPs. Department of Medical Genetics, Cambridge Institute for Medical Research, Cambridge, UK.
25. Qin,Z.S. et al. (2002) Partition-ligation-expectation-maximization algorithm for haplotype inference with single-nucleotide polymorphisms. Am. J. Hum. Genet., 71, 1242-1247.
26. Stram,D.O. et al. (2003) Modeling and E-M estimation of haplotype-specific relative risks from genotype data for a case-control study of unrelated individuals. Hum. Hered., 55, 179-190.
27. Zaykin,D.V. et al. (2002) Testing association of statistically inferred haplotypes with discrete and continuous traits in samples of unrelated individuals. Hum. Hered., 53, 79-91.
28. Kalish,L.A. et al. (2000) Family history and the risk of prostate cancer. Urology, 56, 803-806.
29. Cerhan,J.R. et al. (1999) Family history and prostate cancer risk in a population-based cohort of Iowa men. Cancer Epidemiol. Biomarkers Prev., 8, 53-60.
30. Calle,E.E. et al. (2003) Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults. N. Engl. J. Med., 348, 1625-1638.
31. Giovannucci,E. et al. (2003) Body mass index and risk of prostate cancer in U.S. health professionals. J. Natl Cancer Inst., 95 1240-1244.
32. Amling,C.L. (2005) Relationship between obesity and prostate cancer. Curr. Opin. Urol., 15, 167-171.
33. Rohrmann,S. et al. (2003) Family history of prostate cancer and obesity in relation to high-grade disease and extraprostatic extension in young men with prostate cancer. Prostate, 55, 140-146.
34. Gabriel,S.B. et al. (2002) The structure of haplotype blocks in the human genome. Science, 296, 2225-2229.
35. Florez,J.C. et al. (2004) Haplotype structure and genotype-phenotype correlations of the sulfonylurea receptor and the islet ATP-sensitive potassium channel gene region. Diabetes, 53 1360-1368.
36. Takaku,H. et al. (2003) A candidate prostate cancer susceptibility gene encodes tRNA 3′ processing endoribonuclease. Nucleic Acids Res., 31, 2272-2278.
37. Camp,N.J. et al. (2002) Meta-analysis of associations of the Ser217Leu and Ala541Thr variants in ELAC2 (HPC2) and prostate cancer. Am. J. Hum. Genet., 71, 1475-1478.